Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: Role of persistence

Journal of the National Cancer Institute

Volumn 102, Issue 19, 2010, Pages 1478-1488

  Kjær, Susanne K ^a,b   Frederiksen, Kirsten ^a   Munk, Christian ^a   Iftner, Thomas ^c  

^a INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CANCER CYTODIAGNOSIS; CANCER RISK; CANCER SCREENING; COHORT ANALYSIS; DATA BASE; DENMARK; DISEASE SEVERITY; DNA DETERMINATION; FEMALE; FOLLOW UP; GENOTYPE; GYNECOLOGICAL EXAMINATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; RISK ASSESSMENT; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; COMPLICATION; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; PROSPECTIVE STUDY; RISK FACTOR; TIME; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINA SMEAR; VIROLOGY;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; DENMARK; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 77957835319     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djq356     Document Type: Article

References (22)

1. Muñoz N, Castellsagué X, de González AB, Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine. 2006;24(suppl 3):S1-S10.
2. Schiffman M, Herrero R, Desalle R, et al. The carcinogenicity of human papillomavirus types refects viral evolution. Virology. 2005;337(1):76-84.
3. Khan MJ, Castle PE, Lorincz AT, et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specifc HPV testing in clinical practice. J Natl Cancer Inst. 2005;97(14):1072-1079.
4. Winer RL, Kiviat NB, Hughes JP, et al. Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis. 2005; 191(5):731-738.
5. Berkhof J, Bulkmans NW, Bleeker MC, et al. Human papillomavirus type-specifc 18-month risk of high-grade cervical intraepithelial neoplasia in women with normal or borderline/mildly dyskaryotic smear. Cancer Epidemiol Biomarkers Prev. 2006;15(7):1268-1273.
6. Naucler P, Ryd W, Törnberg S, et al. HPV type-specifc risks of highgrade CIN during 4 years of follow-up: a population-based prospective study. Br J Cancer. 2007;97(1):129-132.
7. Castle PE, Wacholder S, Sherman ME, et al. Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative women. Cancer. 2002;95(10):2145-2151.
8. Peto J, Gilham C, Deacon J, et al. Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort. Br J Cancer. 2004;91(5):942-953.
9. Kjaer S, Høgdall E, Frederiksen K, et al. The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period. Cancer Res. 2006;66(21):10630-10636.
10. Dillner J, Rebolj M, Birembaut P, et al. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ. 2008;337:a1754.
11. Castle PE, Rodríguez AC, Burk RD, et al. Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study. BMJ. 2009;339:h2569.
12. Vernick JP, Steigman CK. The HPV DNA virus hybrid capture assay. What is it and where do we go from here? MLO Med Lab Obs. 2003;35:8-10.
13. Iftner T, Villa LL. Chapter 12: Human papillomavirus technologies. J Natl Cancer Inst Monogr. 2003;31:80-88.
14. Klug SJ, Molijn A, Schopp B, et al. Comparison of the performance of different HPV genotyping methods for detecting genital HPV types. J Med Virol. 2008;80(7):1264-1274.
15. Carstensen B. Regression models for interval censored survival data: application to HIV infection on Danish homosexual men. Stat Med. 1996;15: 2177-2189.
16. Castle PE. Invited commentary: is monitoring of human papillomavirus infection for viral persistence ready for use in cervical cancer screening? Am J Epidemiol. 2008;168(2):138-144.
17. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370(9590): 890-907.
18. Koshiol J, Lindsay L, Pimenta JM, Poole C, Jenkins D, Smith JS. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol. 2008;168(2): 123-137.
19. Schiffman M, Clifford G, Buonaguro F. Classifcation of weakly carcinogenic human papillomavirus types: addressing the limits of the epidemiology at the borderline. Infect Agent Cancer. 2009;4:8.
20. Nøhr B, Jensen A, Frederiksen K, Tabor A, Kjaer SK. Loop electrosur-gical excision of the cervix and subsequent risk for spontaneous preterm delivery: a population-based study of singleton deliveries during a 9-year period. Am J Obstet Gynecol. 2009;201(1:33.e1-e6.
21. Nøhr B, Jensen A, Frederiksen K, Tabor A, Kjaer SK. Depth of cervical cone removed by loop electrosurgical excision and subsequent risk for spontaneous preterm delivery. Obstet Gynecol. 2009;114(6):1232-1238.
22. McCredie MR, Sharples KJ, Paul C, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 2008;9(5): 425-434.